CWM
TMO icon

Centric Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Centric Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-648
Closed -$328K – 164
2023
Q3 		$328K Hold
648
– – 0.14% 84
2023
Q2 		$335K Buy
648
+270
+71% +$146K 0.13% 85
2023
Q1 		$218K Hold
378
– – 0.09% 96
2022
Q4 		$208K Sell
378
-44
-10% -$23.3K 0.11% 95
2022
Q3 		$214K Sell
422
-11
-3% -$6.16K 0.09% 111
2022
Q2 		$235K Buy
433
+9
+2% +$4.95K 0.09% 115
2022
Q1 		$251K Buy
424
+29
+7% +$16.7K 0.08% 137
2021
Q4 		$264K Sell
395
-14
-3% -$8.74K 0.09% 131
2021
Q3 		$234K Hold
409
– – 0.09% 139
2021
Q2 		$206K Buy
+409
New +$193K 0.07% 144

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Centric Wealth Management's TMO Position: Q4 2023 in Review

Centric Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 648 shares — an estimated $328K sold.

Centric Wealth Management first reported a position in TMO in Q2 2021 and held it in 10 quarters. The position peaked at $335K in Q2 2023. 2,491 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Centric Wealth Management reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • Centric Wealth Management sold 648 Thermo Fisher Scientific shares in Q4 2023, an estimated $328K.
  • Centric Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2021 and held it in 10 quarters.
  • Centric Wealth Management's Thermo Fisher Scientific position peaked at $335K in Q2 2023.
  • 2,491 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Centric Wealth Management's 13F filing for Q4 2023, filed 6 Feb 2024.